178 related articles for article (PubMed ID: 15182912)
1. Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco.
Russo EB; Merzouki A; Mesa JM; Frey KA; Bach PJ
J Ethnopharmacol; 2004 Jul; 93(1):99-104. PubMed ID: 15182912
[TBL] [Abstract][Full Text] [Related]
2. The effect of anthocyanosides on night vision.
Levy Y; Glovinsky Y
Eye (Lond); 1998; 12 ( Pt 6)():967-9. PubMed ID: 10325997
[TBL] [Abstract][Full Text] [Related]
3. Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease.
Kiser AK; Mladenovich D; Eshraghi F; Bourdeau D; Dagnelie G
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):444-52. PubMed ID: 16384995
[TBL] [Abstract][Full Text] [Related]
4. The effect of anthocyanosides in a multiple oral dose on night vision.
Zadok D; Levy Y; Glovinsky Y
Eye (Lond); 1999 Dec; 13 ( Pt 6)():734-6. PubMed ID: 10707135
[TBL] [Abstract][Full Text] [Related]
5. Concerning kif, a Cannabis sativa L. preparation smoked in the Rif mountains of northern Morocco.
Merzouki A; Mesa JM
J Ethnopharmacol; 2002 Aug; 81(3):403-6. PubMed ID: 12127244
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of mid-term stability of night vision tests.
Levy Y; Glovinsky Y
Aviat Space Environ Med; 1997 Jul; 68(7):565-8. PubMed ID: 9215460
[TBL] [Abstract][Full Text] [Related]
7. Assessing changes in pupillary size in Rifian smokers of kif (Cannabis sativa L.).
Merzouki A; Molero Mesa J; Louktibi A; Kadiri M; Urbano GV
J Forensic Leg Med; 2008 Jul; 15(5):335-8. PubMed ID: 18511011
[TBL] [Abstract][Full Text] [Related]
8. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
9. Is color vision deficiency an advantage under scotopic conditions?
Simunovic MP; Regan BC; Mollon JD
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3357-64. PubMed ID: 11726645
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
11. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
[TBL] [Abstract][Full Text] [Related]
12. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
[TBL] [Abstract][Full Text] [Related]
13. The Scotopic Sensitivity Tester-1 and the detection of early age-related macular degeneration.
Jackson GR; Felix T; Owsley C
Ophthalmic Physiol Opt; 2006 Jul; 26(4):431-7. PubMed ID: 16792744
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
15. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
[TBL] [Abstract][Full Text] [Related]
16. Marijuana and vision--after ten years' use in Costa Rica.
Dawson WW; Jiménez-Antillon CF; Perez JM; Zeskind JA
Invest Ophthalmol Vis Sci; 1977 Aug; 16(8):689-99. PubMed ID: 885679
[TBL] [Abstract][Full Text] [Related]
17. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
19. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.
Papafotiou K; Carter JD; Stough C
Forensic Sci Int; 2005 Dec; 155(2-3):172-8. PubMed ID: 16226154
[TBL] [Abstract][Full Text] [Related]
20. Kif in Morocco.
Nahas GG; Zeidenberg P; Lefebure C
Int J Addict; 1975; 10(6):977-93. PubMed ID: 1104494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
